Data / Form D filings / Amaryllis Therapeutics, Inc.
Amaryllis Therapeutics, Inc.: Form D filing
Amaryllis Therapeutics, Inc., a company in Cambridge, MA, filed a Form D with the SEC in 2024. The latest, on September 18, 2024, reports $1.5 million sold of a $1.5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 700 MAIN STREET, Cambridge, MA, 02139
- Phone
- (617) 863-3650
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2037518
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 18, 2024 | New notice | $1,500,000 | $1,500,000 | 1 | Sep 10, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jeongseuk Kang | Executive Officer, Director | |
| Emmanouil Karagiannis | Director |
Other companies in Massachusetts that filed recently
- KPK LTH LLC $5 million · Nov 2, 2026
- WEG Consolidated, LLC $675,460 · Oct 30, 2026
- Drowsy Digital, Inc. $37.7 million · Oct 29, 2026
- Netta Argamon SPV LLC $200,000 · Oct 23, 2026
- Crown Topco, LLC $8.3 million · Oct 19, 2026
- Curiosity Brewing Co LLC $245,000 · Oct 13, 2026
Every Form D from the week of Sep 16, 2024 · All recent filings in Massachusetts · All recent Other filings
Read from SEC EDGAR. Amount sold is what Amaryllis Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.